Amit Biswas - Dr Reddys President

<div class='circular--portrait' style='background:#754DEB;color: white;font-size:4em;padding-top: 25px;;'>DR</div>
RDY -- USA Stock  

USD 40.16  1.93  4.59%

Dr. Amit Biswas serves as an Executive Vice President and Head Integrated Product Development of Dr. Reddy Laboratories Ltd July 2011. Amit is a Ph.D and Masters in Polymer Science from Case Western Reserve University, Ohio, USA and a Bachelor of Technology in Chemical Engineering from Indian Institute of Technology, Bombay.
Age: 56  President Since 2016  MBA    
91 40 4900 2900  http://www.drreddys.com

Management Efficiency

The company has Return on Asset of 7.9 % which means that on every $100 spent on asset it made $7.9 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 11.39 % implying that it generated $11.39 on every 100 dollars invested.
The company has 811.73 M in debt with debt to equity (D/E) ratio of 10.9 . This implies that the company may be unable to create cash to meet all of its financial commitments. Dr Reddys Laboratories has Current Ratio of 1.77 which is typical for the industry and considered as normal.

Similar Executives

Showing few of many executives


Sandra BeatyZoetis
John GrayVertex Pharmaceuticals Incorpor
Douglas McCorkleRegeneron Pharmaceuticals
Andrew FentonZoetis
James MichaudPerrigo Company Plc
Ronald JanishPerrigo Company Plc
Charles WagnerVertex Pharmaceuticals Incorpor
Catherine KnuppZoetis
Daniel PlewRegeneron Pharmaceuticals
James DillardPerrigo Company Plc
Michael PartridgeVertex Pharmaceuticals Incorpor
Michael StewartPerrigo Company Plc
Heidi ChenZoetis
Joyce LeeZoetis
George YancopoulosRegeneron Pharmaceuticals
Reshma KewalramaniVertex Pharmaceuticals Incorpor
Ian SmithVertex Pharmaceuticals Incorpor
Peter PowchikRegeneron Pharmaceuticals
Grainne QuinnPerrigo Company Plc
Jeffrey NeedhamPerrigo Company Plc
Michael PariniVertex Pharmaceuticals Incorpor

Company Summary

Reddys Laboratories Limited operates as an integrated pharmaceutical company worldwide. Reddys Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India. Dr Reddys operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 21966 people.Dr Reddys Laboratories Ltd (RDY) is traded on BATS Exchange in USA and employs 21,966 people.

Dr Reddys Laboratories Leadership Team

G Prasad, Co-Chairman of the Board, Chief Executive Officer, Managing DirectorView
MARC KIKUCHI, Chief Executive Officer, North America GenericsView
Hans Hasler, Additional Independent DirectorView
Leo Puri, Non-Executive Independent DirectorView
Sandeep Poddar, Compliance Officer, Company SecretaryView
Satish Reddy, Co-Chairman of the BoardView
Kedar Upadhye, IR Contact OfficerView
Samiran Das, Executive Vice President Head - FTO and GGPMView
Sauri Gudlavalleti, Global Head of Integrated Product Development OrganizationView
YUGANDHAR PUVVALA, Global Head of Supply ChainView
Amit Biswas, Executive Vice President - Integrated Product DevelopmentView
Ravi Bhoothalingam, Non-Executive Independent DirectorView
Alok Sonig, Senior Vice President & India Business Head (Generics)View
Allan Oberman, Non-Executive Independent DirectorView
J Ramachandran, Executive Vice President-Management Systems and Corporate InitiativesView
Prasad Menon, Lead Non-Executive Independent DirectorView
K Rao, Sr. Vice President & Head ? Chemical Technical Operations (CTO)View
Abhijit Mukherjee, COOView
Anil Namboodiripad, Global Head of Proprietary ProductsView
Saumen Chakraborty, President, Chief Financial Officer and Global Head of ITBPE, Legal & Compliance and FMCREView
SANJAY SHARMA, Global Head of ManufacturingView
Shikha Sharma, Non-Executive Independent DirectorView
Sridar Iyengar, Non-Executive Independent DirectorView
Ganadhish Kamat, Executive Vice President and Global Head-QualityView
Sripada Chandrasekhar, President, Global Head of HR and Member of Management CouncilView
Omkar Goswami, Non-Executive Independent DirectorView
Erez Israeli, Chief Operating Officer and Global Head of Generics & PSAIView
Kalpana Morparia, Non-Executive Independent DirectorView
Bharat Doshi, Non-Executive Independent DirectorView
J Moreau, Non-Executive Independent DirectorView
Raymond Vre, Global Head of BiologicsView
Raghav Chari, Senior Vice President - Proprietary ProductsView
Bruce Carter, Non-Executive Independent DirectorView
Saunak Savla, IR Contact OfficerView
Ashok Ganguly, Non-Executive Independent DirectorView
Umang Vohra, Executive Vice President Head - North America GenericsView
M Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets)View
Cartikeya Reddy, Senior Vice President Head - BiologicsView
Anupam Puri, Non-Executive Independent DirectorView
Archana Bhaskar, Chief Human Resource OfficerView
Deepak Sapra, Global Head of PSAIView

Stock Performance Indicators

Return On Equity11.39
Return On Asset7.90
Profit Margin9.50
Current Valuation7.43 B
Shares Outstanding165.77 M
Shares Owned by Insiders0.04
Shares Owned by Institutions13.85
Number of Shares Shorted1.26 M